Indian Journal of Physiotherapy & Occupational Therapy-An International Journal

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Effectiveness of Transcutaneous Electrical Nerve Stimulator (TENS) in Reducing Neuropathic Pain in Patients with Diabetic Neuropathy


Affiliations
1 Department of Physiotherapy, Ravi Nair Physiotherapy College, DMIMS (DU) Sawangi (M) Wardha, India
     

   Subscribe/Renew Journal


Objective: To evaluate the effectiveness of TENS in reducing neuropathic pain in patients with Diabetic Neuropathy.

Design: Prospective Experimental Study.

Participants and Outcome Measure: 20 Patients with a diagnosis of Diabetic Neuropathy were included in the study and they were explained regarding the treatment & its duration. Outcome measures were recorded before & after the treatment session using numerical pain rating scale.

Result: After collecting data statistical analysis was done using Student's paired t test to determine the effect of TENS and it showed a significant difference in reduction in pain post treatment.

Conclusion: It can be concluded that High frequency TENS can be given to Diabetic Neuropathy patients for three weeks to achieve pain reduction.


Keywords

Diabetes, Neuropathic Pain, Transcutaneous Electrical Nerve Stimulator
Subscription Login to verify subscription
User
Notifications
Font Size


  • Watkins PJ. Natural history of diabetic neuropathies. QJ Med. 1990; 77:1209 –1218.

  • Crawford JM. The pancreas. In: Kumar V, Cotran RS, Robbins SL, eds. Basic Pathology. 6th ed. Philadelphia, Pa: WB Saunders Co; 1997:557–578.

  • Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care. 1993; 16: 1446– 1452.

  • Horowitz SH. Diabetic neuropathy. Clin Orthop. 1993; 296:78–85.

  • Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993; 43: 817–824.

  • Tavaloki M, Mojaddidi M, Fadavi H, Malik RA, Pathophysiology and treatment of painful diabetic neuropathy. Curr Pain Headache Rep. 2008; 12: 192–197.

  • Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Rev. 1999; 7: 245–252.

  • Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population e”40 years of age with and without diabetes: 1999–2000 National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27: 1591–1597.

  • Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004; 21: 976–982.

  • Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006; 29: 1518–1522.

  • Boulton AJM. Management of diabetic peripheral neuropathy. Clin Diabetes. 2005; 23: 9–15.

  • Tamer A, Yildiz S, Yildiz N, et al. The prevalence of neuropathy and relationship with risk factors in diabetic patients: a single-center experience. MedPrinc Pract. 2006; 15: 190–194.

  • Valensi P, Giroux C, Seeboth-Ghalavini B, Attali JR. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors. J Diabetes Complications. 1997; 11: 27–34.

  • Booya F, Bandarian F, Larijani B, et al. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005; 5:24.

  • Marks JB. The forgotten complication. Clin Diab. 2005; 23: 3–4.

  • American Diabetes Association survey finds most people with diabetes don’t know about highly prevalent, serious complication. w w w. d i a b e t e s . o r g / f o r - m e d i a / 2005pressreleases/ diabeticneuropathy.jsp. Accessed Sept. 21, 2009.

  • Borssen B, Bergenheim, Lithner F. The epidemiology of foot lesions in diabetic patients aged 15-50 years. Diabetic Med. 1990; 7: 438–444.

  • Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputation. In Diabetes in America. 2nd ed. 1995. Washington, DC. Department of Health and Human Services.

  • Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the U.S. Diabetes Care. 2003; 26: 1790–1795.

  • Reiber GE, Vilekyte L, Bokyo EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999; 22: 157–162.

  • Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care.1990; 13: 513–521. 22. Somers DL, Somers MF. Treatment of neuropathic pain in a patient with diabetic neuropathy using transcutaneous electrical nerve stimulation applied to the skin of the lumbar region. Phys Ther. 1999; 79: 767–775. 23. Dinesh Kumar, MD, Inderjeet S. Julka, MD, Michael S. Alvaro, DPM & Howard J. Marshall, DPM. Diabetic Peripheral Neuropathy. Effectiveness of electrotherapy and amitriptyline for symptomatic relief Diabetes Care. Diabetes Care.1998; 21: 1322- 1325.


Abstract Views: 643

PDF Views: 0




  • Effectiveness of Transcutaneous Electrical Nerve Stimulator (TENS) in Reducing Neuropathic Pain in Patients with Diabetic Neuropathy

Abstract Views: 643  |  PDF Views: 0

Authors

Apeksha O. Yadav
Department of Physiotherapy, Ravi Nair Physiotherapy College, DMIMS (DU) Sawangi (M) Wardha, India
G. J. Ramteke
Department of Physiotherapy, Ravi Nair Physiotherapy College, DMIMS (DU) Sawangi (M) Wardha, India

Abstract


Objective: To evaluate the effectiveness of TENS in reducing neuropathic pain in patients with Diabetic Neuropathy.

Design: Prospective Experimental Study.

Participants and Outcome Measure: 20 Patients with a diagnosis of Diabetic Neuropathy were included in the study and they were explained regarding the treatment & its duration. Outcome measures were recorded before & after the treatment session using numerical pain rating scale.

Result: After collecting data statistical analysis was done using Student's paired t test to determine the effect of TENS and it showed a significant difference in reduction in pain post treatment.

Conclusion: It can be concluded that High frequency TENS can be given to Diabetic Neuropathy patients for three weeks to achieve pain reduction.


Keywords


Diabetes, Neuropathic Pain, Transcutaneous Electrical Nerve Stimulator

References